Skip to content
Healthcare Handout

Healthcare Handout

Everything worth reading in healthcare tech and business.

  • About
  • Handout by Email

Tag: Gilead


New remdesivir trial shows reduction in COVID-19 recovery time from 15 to 11 days; Benefits shown to decline as case severity increases with little effect on ventilated patients

Matthew Herper STAT Author Healthcare HandoutPosted on May 23, 2020May 23, 2020Categories COVID-19, Biotech, PharmaTags Gilead
FacebookTwitterPocket

UPMC using lottery to determine which patients receive remdesivir doses; Weighted to favor essential workers, economically distressed neighborhoods

Melanie Evans, Joseph Walker The Wall Street Journal Author Healthcare HandoutPosted on May 22, 2020May 22, 2020Categories Biotech, COVID-19, PharmaTags Gilead, UPMC Go Deeper
FacebookTwitterPocket

Gilead donates additional 300k remdesivir doses to federal government, enough to treat 30 - 55k more patients

Eric Boodman STAT Author Healthcare HandoutPosted on May 19, 2020May 19, 2020Categories Biotech, COVID-19, PharmaTags Gilead
FacebookTwitterPocket

Gilead agrees to royalty-free generic reproduction of remdesivir for 127 countries through duration of pandemic; United States not included

Berkeley Lovelace Jr. CNBC Author Healthcare HandoutPosted on May 12, 2020May 13, 2020Categories Pharma, Biotech, COVID-19Tags Gilead
FacebookTwitterPocket

HHS outlines plan for remdesivir distribution: drug supply will be given over to states, whose health departments will distribute to hospitals based on determinations of need

Release HHS Author Healthcare HandoutPosted on May 9, 2020May 13, 2020Categories COVID-19, GovernmentTags Gilead
FacebookTwitterPocket

ICER suggests price of $4,500 per course for remdesivir as Gilead considers pricing strategy; Gilead donates 140,000 courses

Andrew Dunn Business Insider Author Healthcare HandoutPosted on May 4, 2020May 13, 2020Categories Biotech, COVID-19, PharmaTags Gilead
FacebookTwitterPocket

FDA grants emergency use authorization for Gilead's remdesivir to treat COVID-19

Adam Feuerstein, Matthew Herper STAT Author Healthcare HandoutPosted on May 1, 2020May 13, 2020Categories Pharma, COVID-19Tags Gilead
FacebookTwitterPocket

Follow The Handout

Twitter: @healthcarehandt

We also have an RSS feed

See our stories in a slack channel

Daily Update

Everything we posted today, in your inbox at 8pm EST.

View by topic

  • ACO
  • Artificial Intelligence
  • Big Tech
  • Biotech
  • CMS
  • Commercial Labs
  • COVID-19
  • Data & Analytics
  • Dental
  • Dermatology
  • Digital Health
  • Digital Therapeutics
  • EHR
  • Employer Benefits
  • FDA
  • Government
  • Health IT
  • Health Policy
  • Home Health Care
  • Hospitals
  • Insurance
  • Medical Devices
  • Medicare Advantage
  • Mental Health
  • Nursing Homes/SNF
  • PBM
  • Pharma
  • Pharmacy
  • Primary Care
  • Public Health
  • Research
  • Retail Healthcare
  • Robotics
  • Small Practices
  • Startups
  • Supply Chain
  • Telehealth
  • Uncategorized
  • Veterans Affairs

Search

  • About
  • Handout by Email
Healthcare Handout Everything worth knowing in healthcare tech and business.
Healthcare business news. Healthcare technology news. Health tech. News aggregator.